SIGA Technologies, Inc.
General ticker "SIGA" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $426.1M (TTM average)
SIGA Technologies, Inc. does not follow the US Stock Market performance with the rate: -32.0%.
Estimated limits based on current volatility of 2.3%: low 3.05$, high 3.19$
Factors to consider:
- Company pays dividends (annually): last record date 2026-04-07, amount 0.60$ (Y18.93%)
- Total employees count: 49 (+6.5%) as of 2025
- US accounted for 83.4% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Government contract risks, Limited non government sales, Geopolitical risks, Regulatory and compliance, Third-party risks
- Current price 13.6% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.67$, 7.13$]
- 2026-12-31 to 2027-12-31 estimated range: [3.69$, 7.10$]
Financial Metrics affecting the SIGA estimates:
- Positive: with PPE of 20.1 at the end of fiscal year the price was neutral
- Positive: 8.77 < Operating cash flow per share per price, % of 9.76
- Positive: 22.58 < Operating profit margin, % of 25.06
- Positive: 7.19 < Return on assets ratio (scaled to [-100,100]) of 9.59
- Positive: -51.61 < Industry operating profit margin (median), % of -17.91
- Negative: negative Industry operating cash flow (median)
- Negative: Investing cash flow per share per price, % of -0.08 <= 2.08
- Positive: Industry inventory ratio change (median), % of -0.31 <= 0
Short-term SIGA quotes
Long-term SIGA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $139.92MM | $138.72MM | $94.57MM |
| Operating Expenses | $56.30MM | $68.74MM | $70.87MM |
| Operating Income | $83.62MM | $69.98MM | $23.70MM |
| Non-Operating Income | $4.16MM | $6.09MM | $6.68MM |
| R&D Expense | $16.43MM | $12.31MM | $19.96MM |
| Income(Loss) | $87.78MM | $76.07MM | $30.38MM |
| Taxes | $19.71MM | $16.86MM | $7.10MM |
| Net Income(Loss)* | $68.07MM | $59.21MM | $23.30MM |
| Stockholders Equity | $196.86MM | $215.80MM | $198.82MM |
| Inventory | $64.22MM | $49.56MM | $49.05MM |
| Assets | $254.35MM | $244.34MM | $219.47MM |
| Operating Cash Flow | $94.80MM | $48.76MM | $43.47MM |
| Capital expenditure | $0.02MM | $0.04MM | $0.36MM |
| Investing Cash Flow | $-0.02MM | $-0.04MM | $-0.36MM |
| Financing Cash Flow | $-43.42MM | $-43.46MM | $-43.55MM |
| Earnings Per Share** | $0.95 | $0.83 | $0.33 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.